glp 1 drugs and crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential Relevance of Glucagon-Like Peptide 1
Description
Wan J, Ferrari C, Tadros M

Oxyntomodulin analogue increases energy expenditure via the Gcg receptor

Higher rates of infertility, miscarriage, gestational diabetes, preeclampsia and other pregnancy complications

Research Article | DOI: Natural GLP-1 Discovery Hidden in Joints Could Revolutionize Arthritis Treatment Rehan Haider 1* Shabana Naz Shah 2 Zameer Ahmed 3 Hina Abbas 4 Geetha Kamara Das 5 Sambreen Zameer 6 1Head of Marketing and Sales, Riggs Pharmaceuticals, Karachi

Non-alcoholic fatty liver disease (NAFLD) can progress to NASH, a major risk factor for liver cancer [95]
